Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Pharmacoeconomic assessment of...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis

Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis

No abstract.

Bibliographic Details
Main Author: G. Ya. Shvarts
Format: Article
Language:English
Published: Romodanov Neurosurgery Institute 2005-06-01
Series:Ukrainian Neurosurgical Journal
Online Access:https://theunj.org/article/view/132316
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://theunj.org/article/view/132316

Similar Items

  • Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone
    by: S. Melamed-Gal, et al.
    Published: (2018-09-01)
  • Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.
    by: Sarah C Starossom, et al.
    Published: (2014-01-01)
  • Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
    by: V. M. Alifirova, et al.
    Published: (2010-08-01)
  • Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone<sup>®</sup>) as a Chemotherapeutic Candidate for the Treatment of <i>Cryptococcus neoformans</i> Infection
    by: Vinicius Alves, et al.
    Published: (2023-07-01)
  • Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
    by: Özlem Taşkapılıoğlu, et al.
    Published: (2012-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs